FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model.
about
FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
FXYD5 (dysadherin) may mediate ...... 4T1 mouse breast cancer model.
@en
type
label
FXYD5 (dysadherin) may mediate ...... 4T1 mouse breast cancer model.
@en
prefLabel
FXYD5 (dysadherin) may mediate ...... 4T1 mouse breast cancer model.
@en
P2093
P2860
P1476
FXYD5 (dysadherin) may mediate ...... 4T1 mouse breast cancer model.
@en
P2093
Carol Asher
Haim Garty
Irina Lubarski-Gotliv
Kuntal Dey
Vecheslav Kalchenco
Yuri Kuznetsov
P2860
P304
P356
10.1152/AJPCELL.00206.2016
P577
2017-05-17T00:00:00Z